ea0026p442 | Thyroid (non cancer) | ECE2011
Bazrafshan H R
, Steinmair M
, Fitz F
, Maleki A R
, Wolf I
, Reichl C
, Beheshti M
, Langsteger W
Introduction: Optimal anti-thyroid regimen for management of GravesÂ’ disease is still a matter of controversy. The aim of this study is determination of remission rate and long-term relapse rate after low-dose anti-thyroid drug therapy.Method: This study is a long-term retrospective study. We selected 100 patients with the diagnosis of GravesÂ’ disease that admitted to our endocrinology clinic from January 2000 until December 2010. All of patien...